Trillium Therapeutics Inc. TRIL

Trillium Therapeutics Inc. Operating Cycle 2011-2025 | TRIL

Annual Operating Cycle Trillium Therapeutics Inc.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	295	314	294	291	299	-	-	-	254	304

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
314	254	293

Operating Cycle of other stocks in the Biotechnology industry

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.78	-0.31 %	$ 793 M	Canada
Aclaris Therapeutics ACRS	6.01	$ 3.03	-0.49 %	$ 234 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	12	$ 1.15	-1.71 %	$ 6.27 M	China
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Aptevo Therapeutics APVO	191	$ 0.6	-35.8 %	$ 166 K	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Amphastar Pharmaceuticals AMPH	195	$ 27.09	1.04 %	$ 1.31 B	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Anika Therapeutics ANIK	325	$ 9.6	1.27 %	$ 141 M	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	349	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	127	-	-	$ 546 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Axon Enterprise AXON	116	$ 584.81	-1.07 %	$ 44.3 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	360	$ 2.44	-3.56 %	$ 15.3 M	USA
AstraZeneca PLC AZN	206	$ 92.79	0.37 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Catalyst Biosciences CBIO	410	$ 12.33	-0.29 %	$ 812 M	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
Celldex Therapeutics CLDX	86.5	$ 26.29	-2.01 %	$ 1.69 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	408	$ 11.07	2.45 %	$ 716 M	USA